The high-cost, type 2 diabetes mellitus patient: An analysis of managed care administrative data

Archives of Public Health

Volumn 72, Issue 1, 2014, Pages

  Meyers, Juliana L ^a   Parasuraman, Shreekant ^b   Bell, Kelly F ^c   Graham, John P ^c   Candrilli, Sean D ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b ASTRAZENECA   (United Kingdom)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Diabetes mellitus; Economics; Health care costs; Type 2

Indexed keywords

EID: 84988811366     PISSN: 07787367     EISSN: 20493258     Source Type: Journal    
DOI: 10.1186/2049-3258-72-6     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta: United States Department of Health and Human Services, Centers for Disease Control and Prevention; 2011
2. American Heart Association: Heart Disease and Stroke Statistics-2008 Update. Dallas: American Heart Association; 2008
3. National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics, 2007. NIH Publication No. 08-3892; 2008 [http://diabetes. niddk.nih.gov/dm/pubs/statistics/DM_Statistics.pdf]
4. American Diabetes Association: Standards of medical care in diabetes-2011 Diabetes Care 2011, 34(Suppl 1):S11-S61
5. Nathan DM, Buse JB, Davidson MB, Ferranni E, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009, 32:193-203
6. American Diabetes Association: Economic costs of diabetes in the US in 2007 Diabetes Care 2008, 31(3):596-615
7. Bullano MF, Fisher MD, Grochulski WD, Meditto L, Willey VJ: Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination projects. Am J Health Syst Pharm 2006, 63(24):2473-2482
8. Clarke PM, Glasziou P, Patel A, Chalmers J, Woodward M, Harrap SB, Salamon JA, ADVANCE Collaborative Group: Event rates, hospital utilization, and costs associated with major complications of diabetes: a multi-country comparative analysis. PLoS Med 2010, 7(2):e1000236
9. Hammer M, Lammert M, Mejias SM, Kern W, Frier BM: Costs of managing severe hypoglycaemia in three European countries. J Med Econ 2009, 12(4):281-290
10. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL: Medication adherence and associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006, 28(10):1712-1725. discussion 1710-1711
11. Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ: Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 2010, 16(4):264-275
12. Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME: Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Policy 2008, 6(2-3):103-112
13. Etemad LR, McCollam PL: Predictors of high-cost managed care patients with acute coronary syndrome. Curr Med Res Opin 2005, 21(12):1977-1984
14. Conwell LJ, Cohen JW: Characteristics of people with high medical expenses in the U.S. civilian noninstitutionalized population, 2002. Statistical Brief #73; 2005 [http://meps.ahrq.gov/mepsweb/data_files/publications/st73/stat73.pdf]
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383
16. Olin GL, Machlin SR: Health Care Expenses in the Community Population, 1999, [MEPS Chartbook No. 11. AHRQ Pub. No. 03-0038.]. Rockville: Agency for Healthcare Research and Quality; 2003
17. Hartmann J: Differences within high-cost patients: how do high-cost patients of different sexes and ages differ in their usage of health service sectors and their distribution of diagnoses? Sydney, Australia: Presentation at the International Health Economics Association; 2013
18. Halanych JH, Safford MM, Keys WC, Person SD, Shikany JM, Kim YI, Centor RM, Allison JJ: Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care 2008, 30(12):2999-3004